Life Science Company News

BioMatrix Expands National Footprint With Acquisition Of City Drugs Specialty Pharmacy

PLANTATION, Fla., June 2, 2020 /PRNewswire/ -- BioMatrix Specialty Pharmacy, a growing leader in the specialty pharmacy space, announced today the acquisition of City Drugs Specialty Pharmacy in New York City, NY. As a result of this transaction, BioMatrix broadens their reach in key therapeutic categories with new payer contracts adding additional covered lives and pharmacy staff extensively experienced in rare and chronic health conditions. The acquisition expands the organization's national footprint to 12 pharmacy locations nationwide.

City Drugs is located on the Upper East Side of Manhattan and specializes in the treatment of complex medical conditions including hepatitis, oncology, auto-immune diseases, and gastroenterology. City Drugs is accredited by URAC, The Joint Commission, and ACHC for Specialty Pharmacy with a Distinction in Oncology.

"BioMatrix continues to bring together a team focused on providing patient-centric, innovative, life changing specialty pharmacy services," stated Nick Karalis, Chief Executive Officer, BioMatrix Specialty Pharmacy. "The acquisition of City Drugs aligns with our strategic growth in specialty and specialty infusion, expanding our therapeutic mix and increasing our payer access. We are excited to welcome City Drugs to the BioMatrix family."

Alex Zeygeril, CEO of City Drugs, is pleased to partner with BioMatrix to expand services and improve patient outcomes. "BioMatrix has a patient-centric focus that echoes our own approach and values," said Zeygeril. "We pride ourselves on improving patient care with high touch services and innovative technology." 

Additional information on BioMatrix and City Drug can be found at www.biomatrixsprx.com and www.citydrugs.com, respectively.

About BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions. Our commitment to every patient is to provide individualized pharmacy services, timely access to care, and focused education and support. We offer a tailored approach for a wide range of therapeutic categories, improving health and empowering patients to experience a higher quality of life.

About City Drugs
City Drugs is a privately-owned New York Based pharmacy, established to meet the growing demand for quality intake, management, and dispensing of complex medications. We provide healthcare providers and patients with high-touch, high-tech medication support services which adhere to the highest quality of care and safety standards.

Media Contact:
Tara Marchese, Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biomatrix-expands-national-footprint-with-acquisition-of-city-drugs-specialty-pharmacy-301069382.html

SOURCE BioMatrix Specialty Pharmacy

- 02 Jun 2020
Back to overview

Enhance your business development with Biotechgate